Boston Partners’s ChemoCentryx CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
AG
Boston Partners's CCXI Position: Q4 2016 in Review
Boston Partners sold out of ChemoCentryx (CCXI) in Q4 2016, closing a stake of 255,815 shares — an estimated $1.54M sold.
Boston Partners first reported a position in CCXI in Q2 2016 and held it in 2 quarters. The position peaked at $1.54M in Q3 2016. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.
- Boston Partners reported no remaining ChemoCentryx position as of Q4 2016 after selling out during the quarter.
- Boston Partners sold 255,815 ChemoCentryx shares in Q4 2016, an estimated $1.54M.
- Boston Partners first reported a position in ChemoCentryx in Q2 2016 and held it in 2 quarters.
- Boston Partners's ChemoCentryx position peaked at $1.54M in Q3 2016.
- 89 funds tracked by Wall St. Rank held ChemoCentryx as of Q4 2016.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.